GE Healthcare

GE Healthcare

Menu
Close

Sorry, your search for: did not find any results

Search Suggestions: Make sure your keyword(s) are spelled correctly Try another keyword(s) Try more general keyword(s)

GE Healthcare and M+W Group Form Strategic Alliance in Vaccines, Insulin and Biopharmaceuticals

December 13, 2011

bacteria

GE Healthcare, the healthcare business of GE and M+W Group, a leading global engineering, construction and project management company, announced today that the companies have formed a strategic alliance aimed at overcoming the lack of key biopharmaceuticals, especially in emerging nations.

The alliance, which will combine GE Healthcare’s expertise in technologies for biopharmaceutical manufacture with M+W Group’s global capabilities in bio-engineering and construction, will assist countries worldwide to become self-sufficient in the manufacture of vital biopharmaceuticals such as vaccines, insulin and biosimilars.

This press kit contains materials and information related to this announcement.

PRESS CONTACT: Val Jones (val.jones@ge.com): +44 791 717 5192


Related

Press Kit Document Downloads

Related Links

Quotes

“We’re delighted to form this alliance with M+W Group, who share our vision of bringing affordable and flexible manufacturing capabilities to countries worldwide, especially the emerging nations. This is a big step forward in bringing better, more affordable healthcare to more people. M+W are one of the foremost global engineering companies in bioengineering. By working together to bring an integrated offering – from financing and construction of the plant, right through to training of the operational staff - we can make it much easier for governments to set up their own facilities.”

Olivier Loeillot, General Manager of Enterprise Solutions, GE Healthcare Life Sciences

______________________________________________________________

“Our global capabilities and strong track record over more than 18 years of delivering high technology facilities for the biotechnology industry is a great fit with the world-class bioprocessing expertise of GE Healthcare. Combining the experience and know-how of our respective companies will bring a new turnkey approach to the much needed local manufacture of potentially life-saving medicines and vaccines. We are delighted to be working together to make a real difference to healthcare delivery world-wide.”

Dr. Tobias Lücke, Managing Director of M+W Process Industries, specialized in Life Science solutions